AAP
ELV icon

Arax Advisory Partners’s Elevance Health ELV Stock Holding History

Arax Advisory Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.19M Buy
8,254
+5,644
+216% +$2.09M 0.02% 630
2026
Q1 		$769K Sell
2,610
-3,791
-59% -$1.25M 0.02% 496
2025
Q4 		$2.19M Sell
6,401
-10,806
-63% -$3.65M 0.06% 220
2025
Q3 		$5.56M Buy
17,207
+15,726
+1,062% +$4.89M 0.08% 206
2025
Q2 		$613K Buy
1,481
+45
+3% +$18.1K 0.03% 348
2025
Q1 		$625K Buy
1,436
+379
+36% +$152K 0.04% 257
2024
Q4 		$390K Sell
1,057
-204
-16% -$85.4K 0.02% 343
2024
Q3 		$655K Buy
1,261
+15
+1% +$8.01K 0.06% 158
2024
Q2 		$675K Buy
1,246
+101
+9% +$53.4K 0.07% 147
2024
Q1 		$594K Buy
1,145
+65
+6% +$32.3K 0.06% 145
2023
Q4 		$509K Buy
1,080
+322
+42% +$149K 0.06% 146
2023
Q3 		$330K Sell
758
-43
-5% -$19.5K 0.04% 196
2023
Q2 		$356K Buy
801
+98
+14% +$45.2K 0.05% 166
2023
Q1 		$323K Buy
703
+47
+7% +$22.4K 0.04% 171
2022
Q4 		$337K Buy
656
+50
+8% +$25.4K 0.05% 160
2022
Q3 		$275K Buy
606
+120
+25% +$57.4K 0.04% 164
2022
Q2 		$234K Buy
486
+26
+6% +$12.9K 0.04% 200
2022
Q1 		$226K Buy
+460
New +$210K 0.03% 223
2018
Q3 		– Sell
-485
Closed -$115K – 652
2018
Q2 		$115K Buy
485
+3
+0.6% +$695 0.05% 141
2018
Q1 		$105K Buy
482
+11
+2% +$2.58K 0.05% 130
2017
Q4 		$105K Buy
471
+5
+1% +$1.06K 0.05% 145
2017
Q3 		$88K Sell
466
-117
-20% -$22.3K 0.04% 158
2017
Q2 		$110K Buy
583
+180
+45% +$32.3K 0.05% 144
2017
Q1 		$66K Buy
403
+180
+81% +$28.6K 0.03% 170
2016
Q4 		$32K Buy
+223
New +$29.9K 0.02% 212

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Arax Advisory Partners's ELV Position: Q2 2026 in Review

Arax Advisory Partners increased its Elevance Health (ELV) stake by 216% in Q2 2026, buying an estimated $2.09M and bringing the position to 8,254 shares worth $3.19M. The position accounts for 0.02% of the portfolio, ranked #630.

Arax Advisory Partners first reported a position in ELV in Q4 2016 and has held it in 25 quarters since. The position peaked at $5.56M in Q3 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Arax Advisory Partners held 8,254 shares of Elevance Health worth $3.19M as of Q2 2026.
  • Arax Advisory Partners bought 5,644 Elevance Health shares in Q2 2026, an estimated $2.09M.
  • Elevance Health made up 0.02% of Arax Advisory Partners's portfolio in Q2 2026, its #630 holding.
  • Arax Advisory Partners first reported a position in Elevance Health in Q4 2016 and has held it in 25 quarters since.
  • Arax Advisory Partners's Elevance Health position peaked at $5.56M in Q3 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.